Brandes AA - Search Results

1

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial.

Lombardi G, De Salvo GL, Brandes AA, Eoli M, Rudà R, Faedi M, Lolli I, Pace A, Daniele B, Pasqualetti F, Rizzato S, Bellu L, Pambuku A, Farina M, Magni G, Indraccolo S, Gardiman MP, Soffietti R, Zagonel V. Lombardi G, et al. Among authors: brandes aa. Lancet Oncol. 2019 Jan;20(1):110-119. doi: 10.1016/S1470-2045(18)30675-2. Epub 2018 Dec 3. Lancet Oncol. 2019. PMID: 30522967 Clinical Trial.

2

Early chemotherapy and concurrent radio-chemotherapy in high grade glioma.

Brandes AA, Rigon A, Zampieri P, Scelzi E, Amistà P, Berti F, Rotilio A, Gardiman M, Fiorentino MV. Brandes AA, et al. J Neurooncol. 1996 Dec;30(3):247-55. doi: 10.1007/BF00177276. J Neurooncol. 1996. PMID: 8943100 Clinical Trial.

3

Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas.

Brandes AA, Scelzi E, Zampieri P, Rigon A, Rotilio A, Amista P, Berti F, Fiorentino MV. Brandes AA, et al. Am J Clin Oncol. 1997 Aug;20(4):364-7. doi: 10.1097/00000421-199708000-00008. Am J Clin Oncol. 1997. PMID: 9256890 Clinical Trial.

4

Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study.

Brandes AA, Rigon A, Zampieri P, Ermani M, Carollo C, Altavilla G, Turazzi S, Chierichetti F, Florentino MV. Brandes AA, et al. Cancer. 1998 Jan 15;82(2):355-61. doi: 10.1002/(sici)1097-0142(19980115)82:2<362::aid-cncr17>3.0.co;2-x. Cancer. 1998. PMID: 9445194 Clinical Trial.

5

Unusual nasal and orbital involvement of glioblastoma multiforme: a case report and review of the literature.

Brandes A, Carollo C, Gardiman M, Scelzi E, Bottin R, Zampieri P, Rigon A, Fiorentino MV. Brandes A, et al. J Neurooncol. 1998 Jan;36(2):179-83. doi: 10.1023/a:1005708107153. J Neurooncol. 1998. PMID: 9525817 Review.

6

Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study.

Brandes AA, Ermani M, Turazzi S, Scelzi E, Berti F, Amistà P, Rotilio A, Licata C, Fiorentino MV. Brandes AA, et al. J Clin Oncol. 1999 Feb;17(2):645-50. doi: 10.1200/JCO.1999.17.2.645. J Clin Oncol. 1999. PMID: 10080610 Clinical Trial.

7

Chemotherapy in patients with recurrent and progressive central neurocytoma.

Brandes AA, Amistà P, Gardiman M, Volpin L, Danieli D, Guglielmi B, Carollo C, Pinna G, Turazzi S, Monfardini S. Brandes AA, et al. Cancer. 2000 Jan 1;88(1):169-74. doi: 10.1002/(sici)1097-0142(20000101)88:1<169::aid-cncr23>3.0.co;2-7. Cancer. 2000. PMID: 10618620

8

Temozolomide in patients with high grade gliomas.

Brandes AA, Pasetto LM, Vastola F, Monfardini S. Brandes AA, et al. Oncology. 2000 Sep;59(3):181-6. doi: 10.1159/000012158. Oncology. 2000. PMID: 11053983 Review.

9

Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study.

Brandes AA, Ermani M, Basso U, Amistà P, Berti F, Scienza R, Rotilio A, Pinna G, Gardiman M, Monfardini S. Brandes AA, et al. Ann Oncol. 2001 Feb;12(2):255-7. doi: 10.1023/a:1008336732273. Ann Oncol. 2001. PMID: 11300334 Free article. Clinical Trial.

10

Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure: a phase II study.

Brandes AA, Ermani M, Basso U, Paris MK, Lumachi F, Berti F, Amistà P, Gardiman M, Iuzzolino P, Turazzi S, Monfardini S. Brandes AA, et al. Oncology. 2002;63(1):38-41. doi: 10.1159/000065718. Oncology. 2002. PMID: 12187069 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

319 results

Search Page